---
title: "Electra Therapeutics tumbles 16% as Q3 revenue hits zero on wider loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305487144.md"
description: "Electra Therapeutics fell 16% to $7.64 after reporting zero Q3 revenue and a widened net loss of $23.9 million."
datetime: "2026-11-13T17:54:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305487144.md)
  - [en](https://longbridge.com/en/news/305487144.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305487144.md)
generator: "portal-rs"
---

# Electra Therapeutics tumbles 16% as Q3 revenue hits zero on wider loss

Electra Therapeutics (ETRA.US) tumbled more than **16%** during regular trading to **$7.64**.

The company reported fiscal third-quarter revenue of **$0**, with its net loss widening to **$23.9 million**, or **$3.47** per share. Research and development expenses totaled **$17.3 million**, while general and administrative expenses were **$7.8 million**.

Electra said it holds **$402.5 million** in cash and securities, which it expects will fund operations into 2029.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ETRA.US](https://longbridge.com/en/quote/ETRA.US.md)

## Related News & Research

- [OrbiMed Advisors reports acquisition of $744,530.60 in Electra Therapeutics common shares](https://longbridge.com/en/news/305089927.md)
- [OrbiMed Advisors Reports Acquisition of $3.61 Million in Electra Therapeutics Common Shares](https://longbridge.com/en/news/304545049.md)
- [Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why](https://longbridge.com/en/news/305493732.md)
- [Electra Therapeutics to Present at Jefferies Global Healthcare Conference](https://longbridge.com/en/news/304282035.md)
- [Berkshire Hathaway (BRK.A) Stock May Trade At A Discount On Record Buybacks](https://longbridge.com/en/news/305497305.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**